Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shulian Shang

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain MetastasisDoug Hanniford, Judy Zhong, Lisa Koetz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2021
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extensionSean J Pittock, Kazuo Fujihara, Jacqueline Palace, et al.
Journal of Translational Medicine|November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survivalJustin Rendleman, Shulian Shang, Christine Dominianni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Annals of Neurology|February 15, 2021
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSDDean M Wingerchuk, Kazuo Fujihara, Jacqueline Palace, et al.
Multiple Sclerosis and Related Disorders|March 6, 2021
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extensionHo Jin Kim, Ichiro Nakashima, Shanthi Viswanathan, et al.
Journal of Translational Medicine|August 4, 2012
Serum microRNAs as biomarkers for recurrence in melanomaErica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, et al.
Journal of the American College of Cardiology|December 4, 2010
Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve)Eugene A Grossi, Nirav Patel, Y Joseph Woo, et al.
Cancer Cell|July 12, 2011
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasisAvital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain MetastasisDoug Hanniford, Judy Zhong, Lisa Koetz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2021
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extensionSean J Pittock, Kazuo Fujihara, Jacqueline Palace, et al.
Journal of Translational Medicine|November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survivalJustin Rendleman, Shulian Shang, Christine Dominianni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Annals of Neurology|February 15, 2021
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSDDean M Wingerchuk, Kazuo Fujihara, Jacqueline Palace, et al.
Multiple Sclerosis and Related Disorders|March 6, 2021
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extensionHo Jin Kim, Ichiro Nakashima, Shanthi Viswanathan, et al.
Journal of Translational Medicine|August 4, 2012
Serum microRNAs as biomarkers for recurrence in melanomaErica B Friedman, Shulian Shang, Eleazar Vega-Saenz de Miera, et al.
Journal of the American College of Cardiology|December 4, 2010
Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve)Eugene A Grossi, Nirav Patel, Y Joseph Woo, et al.
Cancer Cell|July 12, 2011
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasisAvital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, et al.
Pageof 2